In Brief: Wyeth-Lederle Rotashield
Wyeth-Lederle Rotashield: Advisory Commission on Immunization Practices will meet Feb. 11-12 to discuss recommendations on use of Rotashield (rotavirus vaccine) in the routine childhood immunization schedule. The commission will also discuss alopecia associated with hepatitis B vaccination; influenza vaccination and Guillain Barre syndrome; and Vaccine Injury Compensation Program. Meeting begins at 8:30 a.m. at Centers for Disease Control & Prevention headquarters in Atlanta...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth